Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial.
Echegaray MVF, Mello RP, Magnavita GM, Leal GC, Correia-Melo FS, Jesus-Nunes AP, Vieira F, Bandeira ID, Caliman-Fontes AT, Telles M, Guerreiro-Costa LNF, Marback RF, Souza-Marques B, Lins-Silva DH, Santos-Lima C, Cardoso TA, Kapczinski F, Lacerda ALT, Quarantini LC. Echegaray MVF, et al. Among authors: souza marques b. Trends Psychiatry Psychother. 2023 Sep 17. doi: 10.47626/2237-6089-2022-0593. Online ahead of print. Trends Psychiatry Psychother. 2023. PMID: 37717263 Free article.
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study.
Bandeira ID, Leal GC, Correia-Melo FS, Souza-Marques B, Silva SS, Lins-Silva DH, Mello RP, Vieira F, Dorea-Bandeira I, Faria-Guimarães D, Carneiro B, Caliman-Fontes AT, Kapczinski F, Miranda-Scippa Â, Lacerda ALT, Quarantini LC. Bandeira ID, et al. Among authors: souza marques b. J Psychiatr Res. 2023 Aug;164:229-234. doi: 10.1016/j.jpsychires.2023.06.028. Epub 2023 Jun 23. J Psychiatr Res. 2023. PMID: 37385001 Clinical Trial.
Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study.
Leal GC, Souza-Marques B, Mello RP, Bandeira ID, Caliman-Fontes AT, Carneiro BA, Faria-Guimarães D, Guerreiro-Costa LNF, Jesus-Nunes AP, Silva SS, Lins-Silva DH, Fontes MA, Alves-Pereira R, Cordeiro V, Rugieri-Pacheco S, Santos-Lima C, Correia-Melo FS, Vieira F, Sanacora G, Lacerda ALT, Quarantini LC. Leal GC, et al. Among authors: souza marques b. J Affect Disord. 2023 Jun 1;330:7-15. doi: 10.1016/j.jad.2023.02.151. Epub 2023 Mar 4. J Affect Disord. 2023. PMID: 36871913 Clinical Trial.
Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial.
Beanes G, Caliman-Fontes AT, Souza-Marques B, Silva HDS, Leal GC, Carneiro BA, Guerreiro-Costa LNF, Figueiredo AV, Figueiredo CAV, Lacerda ALT, Costa RDS, Quarantini LC. Beanes G, et al. Among authors: souza marques b. Clin Neuropharmacol. 2022 Nov-Dec 01;45(6):151-156. doi: 10.1097/WNF.0000000000000517. Epub 2022 Sep 11. Clin Neuropharmacol. 2022. PMID: 36093918 Clinical Trial.
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression.
Souza-Marques B, Telles M, Leal GC, Faria-Guimarães D, Correia-Melo FS, Jesus-Nunes AP, Vieira F, Souza L, Lins-Silva D, Mello RP, Guerreiro-Costa L, Bandeira ID, Lacerda ALT, Sampaio AS, Quarantini LC. Souza-Marques B, et al. J Clin Psychopharmacol. 2022 Jul-Aug 01;42(4):408-412. doi: 10.1097/JCP.0000000000001571. Epub 2022 Jun 21. J Clin Psychopharmacol. 2022. PMID: 35727083 Clinical Trial.
Letter to the Editor: Antidepressant and Antisuicidal Effects of Esketamine in Adolescents with Major Depressive Disorder and Suicidal Ideation: A Case Series.
Faria-Guimarães D, Vieira F, Souza-Marques B, Silva SS, Bandeira ID, Souza LS, Alves-Pereira R, Fontes M, Mello RP, Leal GC, Cardoso TA, Kapczinski F, Lacerda ALT, Sampaio AS, Quarantini LC. Faria-Guimarães D, et al. Among authors: souza marques b. J Child Adolesc Psychopharmacol. 2022 Aug;32(6):366-367. doi: 10.1089/cap.2022.0013. Epub 2022 Jun 16. J Child Adolesc Psychopharmacol. 2022. PMID: 35708566 No abstract available.
Suicide attempt, impulsivity, and exposure to trauma in college students.
Lira SB, Vieira F, Cavalcanti DE, Souza-Marques B, Netto LR, Correia-Melo FS, Leal GC, Pereira JL, Santos LL, Guedes GM, Teles CA, Cardoso TA, Miranda-Scippa Â, Kapczinski F, Lacerda ALT, Koenen KC, Turecki G, Quarantini LC. Lira SB, et al. Among authors: souza marques b. Braz J Psychiatry. 2022 May-Jun;44(3):279-288. doi: 10.1590/1516-4446-2021-2175. Braz J Psychiatry. 2022. PMID: 35262616 Free PMC article.
Executive functions in school-aged children exposed to airborne manganese: A multilevel analysis.
Carvalho CF, Santos-Lima C, Souza-Marques B, de Mendonça Filho EJ, Lorenzo RG, França RJAF, Araújo-Dos-Santos B, Veloso TJ, Rodrigues JLG, Araújo CFS, Dos Santos NR, Bandeira MJ, Anjos ALS, Mergler D, Abreu N, Menezes-Filho JA. Carvalho CF, et al. Among authors: souza marques b. Environ Res. 2022 Jul;210:112940. doi: 10.1016/j.envres.2022.112940. Epub 2022 Feb 17. Environ Res. 2022. PMID: 35182597
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression.
Jesus-Nunes AP, Leal GC, Correia-Melo FS, Vieira F, Mello RP, Caliman-Fontes AT, Echegaray MVF, Marback RF, Guerreiro-Costa LNF, Souza-Marques B, Santos-Lima C, Souza LS, Bandeira ID, Kapczinski F, Lacerda ALT, Quarantini LC. Jesus-Nunes AP, et al. Among authors: souza marques b. Hum Psychopharmacol. 2022 Jul;37(4):e2836. doi: 10.1002/hup.2836. Epub 2022 Feb 18. Hum Psychopharmacol. 2022. PMID: 35179810 Clinical Trial.
Drugs age-of-onset as a signal of later post-traumatic stress disorder: Bayesian analysis of a census protocol.
Santos LL, Netto LR, Cavalcanti-Ribeiro P, Pereira JL, Souza-Marques B, Argolo F, Lira SB, Fontes G, Moreira EC, Anthony JC, Koenen KC, Quarantini LC; Trauma, Anxiety Disorders Study Group-TADSG. Santos LL, et al. Among authors: souza marques b. Addict Behav. 2022 Feb;125:107131. doi: 10.1016/j.addbeh.2021.107131. Epub 2021 Oct 13. Addict Behav. 2022. PMID: 34763301
18 results